AbbVie's Next Parkinson's Treatment Partner by End of 2025? | Categorical | | | 2 months ago | |
Jazz Pharmaceuticals Lawsuit Against Avadel by June 2025? | Binary | | | 2 months ago | |
Will Jazz's zanidatamab-hrii reach $100 million in sales by the end of 2025? | Binary | | | 1 month ago | |
In how many countries will zanidatamab-hrii be approved for HER2+ BTC by the end of 2025? | Categorical | | | 1 month ago | |
What will be the real-world response rate of zanidatamab-hrii by the end of 2025? | Categorical | | | 1 month ago | |
Will zanidatamab-hrii be approved for additional indications by the end of 2025? | Binary | | | 1 month ago | |
Will Jazz Pharmaceuticals' stock price rise by 20% or more by the end of 2025? | Binary | | | 1 month ago | |
What will be the market share of zanidatamab-hrii in HER2+ BTC treatments by the end of 2025? | Categorical | | | 1 month ago | |
Main Regulatory Challenge for LUMRYZ in 2025? | Categorical | | | 2 months ago | |
AbbVie's Vyalev $500M Sales Milestone by October 2025? | Binary | | | 2 months ago | |
Avadel's LUMRYZ Major Recall by End of 2025? | Binary | | | 2 months ago | |
Dominant Narcolepsy Treatment Company by End of 2025? | Categorical | | | 2 months ago | |
